Cancer Biology & Therapy, Volume 14, Issue 4 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Biology & Therapy, Volume 14, Issue 4 (2013)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Volume 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2011 Vol 10, 2010 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Review

Review Article
PKC signaling in glioblastoma
Anália do Carmo, Joana Balça-Silva, Diana Matias & Maria Lopes
Pages: 287-294
Published online: 28 Jan 2013
AbstractforPKC signaling in glioblastoma | PDF (946.3 KB)
  • 897 Views
  • 51 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Therapeutic strategies targeting cancer stem cells
Xiaoyan Ning, Jianchang Shu, Yiqi Du, Qiwen Ben & Zhaoshen Li
Pages: 295-303
Published online: 28 Jan 2013
AbstractforTherapeutic strategies targeting cancer stem cells | Full Text | References | PDF (754.9 KB)
  • 2750 Views
  • 56 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Mechanisms of resistance to EGFR targeted therapies
Gorjan Hrustanovic, Bianca J. Lee & Trever G. Bivona
Pages: 304-314
Published online: 28 Jan 2013
AbstractforMechanisms of resistance to EGFR targeted therapies | Full Text | References | PDF (896.6 KB)
  • 2635 Views
  • 40 CrossRef citations
  • 0Altmetric
Free Access

Meeting Report

Meeting Report
Metabolic reprogramming of the immune response in the tumor microenvironment
Susan A. McCarthy, R. Allan Mufson, Edward J. Pearce, Jeffrey C. Rathmell & T. Kevin Howcroft
Pages: 315-318
Published online: 28 Jan 2013
AbstractforMetabolic reprogramming of the immune response in the tumor microenvironment | Full Text | References | PDF (600.9 KB)
  • 1317 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines
Maria Mendonça-Torres & Stephen Roberts
Pages: 319-326
Published online: 28 Jan 2013
AbstractforThe translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines | PDF (1.3 MB)
  • 643 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Mammaglobin peptide as a novel biomarker for breast cancer detection
Julie M. Galvis-Jiménez, Hernando Curtidor, Manuel A. Patarroyo, Pedro Monterrey & Sandra R. Ramírez-Clavijo
Pages: 327-332
Published online: 28 Jan 2013
AbstractforMammaglobin peptide as a novel biomarker for breast cancer detection | Full Text | References | PDF (982.2 KB)
  • 1039 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1
Ian M. Zitron, David O. Kamson, Sam Kiousis, Csaba Juhász & Sandeep Mittal
Pages: 333-339
Published online: 28 Jan 2013
AbstractforIn vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1 | Full Text | References | PDF (1.9 MB)
  • 938 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Article
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial
Jeffrey Infante, Hendrik-Tobias Arkenau, Johanna Bendell, Mark Rubin, David Waterhouse, George Jones, David Spigel, Cassie Lane, John Hainsworth & Howard Burris, III
Pages: 340-346
Published online: 28 Jan 2013
AbstractforLenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial | PDF (842.1 KB)
  • 284 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Nishant Gandhi, Aaron T. Wild, Sivarajan T. Chettiar, Khaled Aziz, Yoshinori Kato, Rajendra P. Gajula, Russell D. Williams, Jessica A. Cades, Anvesh Annadanam, Danny Song, Yonggang Zhang, Russell K. Hales, Joseph M. Herman, Elwood Armour, Theodore L. DeWeese, Edward M. Schaeffer & Phuoc T. Tran
Pages: 347-356
Published online: 28 Jan 2013
AbstractforNovel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells | Full Text | References | PDF (2 MB)
  • 1170 Views
  • 38 CrossRef citations
  • 0Altmetric
Free Access
Article
Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model
Rebecca E. De Angel, Jorge M. Blando, Matthew G. Hogan, Michael A. Sandoval, Dharmika S.P. Lansakara-P, Sarah M. Dunlap, Stephen D. Hursting & Zhengrong Cui
Pages: 357-364
Published online: 28 Jan 2013
AbstractforStearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model | Full Text | References | PDF (2.2 MB)
  • 827 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma
Songqing Fan, Susan Müller, Zhuo Chen, Pan Lin, Mourad Tighiouart, Dong Shin, Fadlo R. Khuri & Shi-Yong Sun
Pages: 365-369
Published online: 28 Jan 2013
AbstractforPrognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma | PDF (1.2 MB)
  • 207 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma
Xiangmin Tong, Xuewu Zhang, Jian Fan, Yin Tong, Shuangshuang Li, Jie Jin & Hangping Yao
Pages: 370-377
Published online: 29 Jan 2013
AbstractforThe RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma | Full Text | References | PDF (2.3 MB)
  • 615 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
Yingying Yang et al.
Article | Published online: 24 Jul 2024
Open Access
Association between the IL1B-511 C>T polymorphism and the risk of hematologic malignancies: data from a meta-analysis
Fabíola Silva Alves-Hanna et al.
Review Article | Published online: 22 Jul 2024
Open Access
Natural killer cell memory: challenges and opportunities for cancer immunotherapy
Yuhua Qu et al.
Review Article | Published online: 10 Jul 2024
Open Access
Jmjd2c maintains the ALDHbri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma
Min Wang et al.
Article | Published online: 8 Jul 2024
Open Access